The pharmaceutical firm Almirall, a CataloniaBio & HealthTech member, launches its sixth call for proposals with the aim of establishing collaborations in dermatological research through the open innovation platform AlmirallShare.
The call is addressed to biotech start-ups, pharmaceutical companies, universities and research centres over the world. The submission period is open until October 31, 2021.
“AlmirallShare has increasingly earned recognition from the scientific community since was launched in 2017. We truly believe in groundbreaking innovation and cross collaboration as the way to succeed, and AlmirallShare allows us to strengthen our network to identify new opportunities in medical dermatology" says Maribel Crespo, Almirall’s Research Alliances and AlmirallShare Leader.
Since 2017, Almirall has received 410 proposals and has established eight collaborations based on therapies (August Pi i Sunyer Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, University of Turin and University of South Australia), targets (Dublin City University and University of Namur), and preclinical models (University College Dublin and University of Sheffield).
Comments